Redhill Biopharma Q3 EPS $(0.03) Beats $(0.38) Estimate, Sales $1.4M Miss $1.77M Estimate

Redhill Biopharma (NASDAQ:RDHL) reported quarterly losses of $(0.03) per share which beat the analyst consensus estimate of $(0.38) by 92.11 percent. This is a 25 percent increase over losses of $(0.04) per share from

Benzinga · 11/19/2019 12:03

Redhill Biopharma (NASDAQ:RDHL) reported quarterly losses of $(0.03) per share which beat the analyst consensus estimate of $(0.38) by 92.11 percent. This is a 25 percent increase over losses of $(0.04) per share from the same period last year. The company reported quarterly sales of $1.4 million which missed the analyst consensus estimate of $1.77 million by 20.90 percent. This is a 36.54 percent decrease over sales of $2.206 million the same period last year.